Meeting
2024 ASCO Annual Meeting
Estimating adult cancer cachexia prevalence and impact on survival in the US: Real-world data analysis.
Authors
Eric Roeland
OHSU Knight Cancer Institute, Portland, OR
Eric Roeland , Jeffrey Crawford , Richard Francis Dunne , Ira Allen Jacobs , John Groarke , Michelle I Rossulek , Nilo B. Cater , Philip D. Bonomi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Quality Care/Health Services Research
Track
Care Delivery and Quality Care
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 11141)
DOI
10.1200/JCO.2024.42.16_suppl.11141
Abstract #
11141
Poster Bd #
336
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer.
First Author: Sherry Shen
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of body-mass index (BMI) with age, PSA, and survival in metastatic prostate cancer.
First Author: Martin W. Schoen
Poster
2023 ASCO Annual Meeting
Evaluation of cachexia and outcomes in patients with aggressive B-cell non-Hodgkin lymphoma.
First Author: Nicholas Demetriou
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Trajectories of body weight change and survival among mCRC patients treated with systemic therapy: Pooled analysis from the ARCAD database.
First Author: Jan Franko